News

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

02 December 2022

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

29 July 2022

Community engagement – shaping the long-acting technologies pipeline

29 July 2022

Delivering innovations to low- and middle-income countries

25 April 2022

Saving lives through long-acting injectable innovation

24 April 2022

Investing in TB prevention strategies with Long-Acting injectables

24 March 2022

Reducing the burden of TB in the world’s most in need communities with long-acting injectables

24 March 2022

Living with TB - my experience

24 March 2022

Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C

21 September 2021

Liverpool launches new Centre of Excellence for Long-acting Therapeutics

12 January 2021

News

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

02 December 2022

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

29 July 2022

Community engagement – shaping the long-acting technologies pipeline

29 July 2022

Delivering innovations to low- and middle-income countries

25 April 2022

Saving lives through long-acting injectable innovation

24 April 2022

Investing in TB prevention strategies with Long-Acting injectables

24 March 2022

Reducing the burden of TB in the world’s most in need communities with long-acting injectables

24 March 2022

Older Stories

Why choose Liverpool?
It’s an important question. And there are thousands of answers.

Study with Liverpool

Find a course

Search courses

Select type

Our courses

Research with real world impact

Our research

Research

Postgraduate Research

Research and business collaboration

Advancing knowledge to transform lives

About us

Our story

Key information

Our locations

Search

Find a course

Select type

News

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

Community engagement – shaping the long-acting technologies pipeline

Delivering innovations to low- and middle-income countries

Saving lives through long-acting injectable innovation

Investing in TB prevention strategies with Long-Acting injectables

Reducing the burden of TB in the world’s most in need communities with long-acting injectables

Living with TB - my experience

Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C

Liverpool launches new Centre of Excellence for Long-acting Therapeutics

News

Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

Community engagement – shaping the long-acting technologies pipeline

Delivering innovations to low- and middle-income countries

Saving lives through long-acting injectable innovation

Investing in TB prevention strategies with Long-Acting injectables

Reducing the burden of TB in the world’s most in need communities with long-acting injectables